Design Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Design Therapeutics (Nasdaq: DSGN) announced management will participate in two investor fireside chats in early December 2025: Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 3:30 p.m. ET in New York and Evercore 8th Annual Healthcare Conference on Thursday, December 4, 2025 at 10:00 a.m. ET in Coral Gables, Florida.

Live webcasts will be available on the company’s investor site at www.designtx.com and will be archived for at least 30 days after each presentation.

CARLSBAD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in fireside chats at the following upcoming investor conferences:

• Piper Sandler 37^th Annual Healthcare Conference on Wednesday, December 3, 2025, at 3:30 p.m. ET in New York, NY
• Evercore 8^th Annual Healthcare Conference on Thursday, December 4, 2025, at 10:00 a.m. ET in Coral Gables, FL

Live webcasts of each fireside chat will be available here and in the investors section of the company’s website at www.designtx.com. The webcasts will be archived for at least 30 days following each presentation.

About Design Therapeutics
Design Therapeutics is a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC^® gene targeted chimera small molecules. The company’s GeneTAC^® molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. In addition to its clinical-stage GeneTAC^® programs, DT-216P2, in development for patients with Friedreich ataxia, and DT-168, for Fuchs endothelial corneal dystrophy, the company is advancing DT-818 for myotonic dystrophy type-1, and a program in Huntington’s disease. Discovery efforts are underway for multiple genomic medicines. For more information, please visit designtx.com.

Contact:
Renee Leck
THRUST Strategic Communications
renee@thrustsc.com

FAQ

When will Design Therapeutics (DSGN) present at the Piper Sandler healthcare conference?

Design Therapeutics management will present at Piper Sandler on Wednesday, December 3, 2025 at 3:30 p.m. ET in New York.

When is Design Therapeutics (DSGN) scheduled to speak at the Evercore healthcare conference?

Design Therapeutics management will present at Evercore on Thursday, December 4, 2025 at 10:00 a.m. ET in Coral Gables, Florida.

Where can investors watch the live webcast of DSGN fireside chats?

Live webcasts will be available on the company’s investor website at www.designtx.com and via the conference webcast links.

How long will Design Therapeutics (DSGN) archive the conference webcasts?

The webcasts will be archived for at least 30 days following each presentation.

Will Design Therapeutics (DSGN) discuss clinical programs during the December 2025 fireside chats?

The announcement states management will participate in fireside chats; specific agenda items such as clinical program updates were not detailed.

Can international investors access the DSGN webcasts and archives?

Yes; the announcement notes live webcasts and archived recordings will be available on the company investor site, accessible to viewers online.